Skip to main content

Contineum Therapeutics to Present at September Investor Conferences

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced that management is scheduled to present at the following investor conferences in September.

Cantor Global Healthcare Conference 2025 – fireside chat on Thursday, September 4, 2025, at 9:10 a.m. ET.

Morgan Stanley 23rd Annual Global Healthcare Conferencefireside chat on Monday, September 8, 2025, at 8:30 a.m. ET.

Baird 2025 Global Healthcare Conference – fireside chat on Tuesday, September 9, 2025, at 2:00 p.m. ET.

An audio webcast of the presentations can be accessed on the Investors section of Contineum’s website. A replay of the webcasts will also be available.

About Contineum Therapeutics

Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need. Contineum is advancing a pipeline of internally-developed programs with multiple drug candidates now in clinical trials. PIPE-791 is an LPA1 receptor antagonist in clinical development for idiopathic pulmonary fibrosis, progressive multiple sclerosis and chronic pain. PIPE-307 is a selective inhibitor of the M1 receptor in clinical development for relapsing-remitting multiple sclerosis and major depressive disorder. For more information, please visit www.contineum-tx.com.

Contacts

Steve Kunszabo

Contineum Therapeutics

Senior Director, Investor Relations & Corporate Communications

858-649-1158

skunszabo@contineum-tx.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.82
-3.21 (-1.44%)
AAPL  258.70
-4.07 (-1.55%)
AMD  229.33
-8.70 (-3.66%)
BAC  50.98
-0.54 (-1.04%)
GOOG  253.58
+2.24 (0.89%)
META  729.85
-3.42 (-0.47%)
MSFT  523.36
+5.70 (1.10%)
NVDA  178.69
-2.47 (-1.36%)
ORCL  271.24
-3.91 (-1.42%)
TSLA  433.85
-8.75 (-1.98%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.